Oligodendroglioma other imaging findings

Oligodendroglioma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Oligodendroglioma from other Diseases
Epidemiology & Demographics
Risk Factors
Screening
Natural History, Complications, and Prognosis
Diagnosis
Staging
History & Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Oligodendroglioma other imaging findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Oligodendroglioma other imaging findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Oligodendroglioma other imaging findings
CDC on Oligodendroglioma other imaging findings
Oligodendroglioma other imaging findings in the news
Blogs on Oligodendroglioma other imaging findings
Directions to Hospitals Treating Oligodendroglioma
Risk calculators and risk factors for Oligodendroglioma other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Other Imaging Findings

Other imaging studies for oligodendroglioma include:

Magnetic Resonance Spectroscopy

• N-acetyl aspartate (NAA) peak is dominant
• Choline-to-creatine ratio of less than 3:1

References

Template:WikiDoc Sources